Clinical Trial Update: The Study of Drotrecogin Alfa (Activated) in a Subpopulation of Adult Patients With Severe Sepsis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for drotrecogin alfa (activated) in a subpopulation of adults with severe sepsis. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Drugs mentioned

• Xigris (Drotrecogin alfa (activated))

Snippet

Sponsor: Eli Lilly and Company | Conditions: Sepsis | Phase 4 | Status: COMPLETED